0001209191-18-005381.txt : 20180125 0001209191-18-005381.hdr.sgml : 20180125 20180125163049 ACCESSION NUMBER: 0001209191-18-005381 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180124 FILED AS OF DATE: 20180125 DATE AS OF CHANGE: 20180125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FALVEY MICHAEL CENTRAL INDEX KEY: 0001286197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 18548599 MAIL ADDRESS: STREET 1: C/O KARYOPHARM THERAPEUTICS INC. STREET 2: 85 WELLS AVENUE, 2ND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-24 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001286197 FALVEY MICHAEL C/O KARYOPHARM THERAPEUTICS INC. NEWTON MA 02459 0 1 0 0 EVP, CFO & Treasurer Stock Option (right to buy) 10.45 2018-01-24 4 A 0 95000 0.00 A 2028-01-23 Common Stock 95000 95000 D This option was granted on January 24, 2018. The shares underlying this option vest as to 25% of the shares on January 24, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter. /s/ Christopher B. Primiano, Attorney-in-Fact for Michael Falvey 2018-01-25